Spread the loveIn a landmark deal that could reshape the dynamics of the pharmaceutical industry, Sun Pharmaceutical Industries Ltd. has announced its acquisition of Organon for a staggering $11.8 ...

Opportunities in the pharmaceutical industry include innovation in biologics, growth in GLP-1 therapies and precision oncology, rising demand for advanced treatments, and expanding manufacturing in ...

Again, my previous article included more industry overview, but I thought I would add a little more here. I am writing this article comparing my tier two companies for a couple of reasons. First, this ...

In today’s Pharmaceutical Executive Daily, Antengene and UCB enter a billion-dollar global licensing agreement for a bispecific T-cell engager, Teva signs a $400 million strategic growth capital ...

I will start out by explaining my investing philosophy so readers will understand why I see opportunity in an industry that appears to be under pressure by tariff threats from the administration. I do ...

The "Excipients in Pharmaceuticals: Global Markets to 2029" report has been added to ResearchAndMarkets.com's offering. The Excipients in Pharmaceuticals Market was valued at USD 9.7 billion in 2024, ...

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/4fj74t/pharmaceutical) has announced the addition of the "Pharmaceutical ...

In the fast-paced and cutthroat world of business, conducting thorough company analysis is essential for investors and industry experts. In this article, we will undertake a comprehensive industry ...

New York, May 08, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Pharmaceutical & Healthcare Annual Deals Analysis: M&A and ...

Agios Pharmaceuticals (NASDAQ:AGIO) is gearing up to announce its quarterly earnings on Thursday, 2025-05-01. Here's a quick overview of what investors should know before the release. Analysts are ...

The five largest U.S. pharmaceutical companies by market cap — Eli Lilly, Johnson & Johnson, Merck, AbbVie and Pfizer — reported combined earnings of $81.9 billion in 2022, an $8 billion increase from ...

DUBLIN--(BUSINESS WIRE)-- Research and Markets (http://www.researchandmarkets.com/research/81c5d0/china_pharmaceutic) has announced the addition of the "China ...